(Q54707080)

English

Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

0 references

Shailendra K. Saxena

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Rentala Madhubala

object named as

Rentala Madhubala

4

0 references

author name string

Poonam Tewary

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Bindu Sukumaran

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

22

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

23-24

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

3053-3060

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Visceral leishmaniasis: more prevalent and more problematic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

DNA vaccines: technology and application as anti-parasite and anti-microbial agents

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

based on heuristic

inferred from DOI database lookup

Designer vaccines for parasitic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunization with recombinant LD1 antigens protects against experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Leishmania vaccines: old and new.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Leishmania donovani: Characterization and Expression of ORFF, a Gene Amplified from the LDI Locus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

A frequently amplified region in Leishmania contains a gene conserved in prokaryotes and eukaryotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

A multicopy, extrachromosomal DNA in Leishmania infantum contains two inverted repeats of the 27.5-kilobase LD1 sequence and encodes numerous transcripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG motifs as immune adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.02.007

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54707080&oldid=1775335155"